Change of Youth League Committee of Group Company
Release time:
2020-08-14
Group Company Youth League Committee Change
Chi Lifan Elected New Youth League Secretary
News 4# October 13 , the Communist Youth League Jianfeng Group Committee held a congress and elected a new committee. Group company office chi lifan was elected as the new secretary of the youth league.
The change of the Youth League Committee was carried out under the guidance of the Party Committee of the Group Company. After full deliberation and extensive consultation, 11 young employees, including Chi Lifan, Liu Yang, Sheng Da, Guo Li, Zong Ning, Ying Chaojun, Ying Fu, Su Dabin, Wu Minzhe, Han Changliang and Sheng Junyong, were elected as members of the new committee. At the first meeting of the new committee, Chi Lifan was elected as the secretary of the new branch committee by secret ballot. Qin Xuping, member of the Party Committee of
Group Company and director of the Party-Mass Work Department, attended the general meeting of the Youth League Committee and delivered a speech. He said that the Communist Youth League is the party's assistant and reserve army, and the bridge and link between the party and the youth. He hopes that the new Youth League Committee can further unite and lead the majority of young employees, play the role of a new force and commando in the production and operation management of enterprises, and focus on the party and government. The center carries out work in a planned, purposeful and targeted manner, organizes and carries out various activities, and fully mobilizes the enthusiasm of the youth; pay attention to grasping the ideological trends of the majority of young people, understand their work, study, etc., and provide a reference basis for the company's correct decision-making; actively assist in the ideological work of young people to ensure the effective implementation of the company's various tasks; guide the youth to focus on Key and difficult issues in production and operation, and timely summarize the good practices and good experience of the unit; create an atmosphere of striving to be "learning employees" among young people, guide employees to strengthen learning, enrich knowledge reserves, optimize knowledge structure, continuously improve work ability, business knowledge and skills, and cultural literacy, and use their intelligence and talents in work practice. Realize your own value and ideal pursuit. (this newspaper reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31